AssetID: 54316168
Headline: Weight-Loss Drug Wegovy comes to China Amid Rising Demand
Caption: Novo Nordisk has officially launched its weight-loss drug Wegovy in China after receiving approval in June. The move pits it against rival Eli Lilly, whose treatment, Zepbound, is yet to hit shelves in the world's second-largest pharmaceutical market.
Keywords: Health & Wellbeing,Wegovy,weight-loss drug,China,Novo Nordisk,eli Lilly,Zepbound,rival,obesity,sttruggling,injections,thousand,yuan,dollars,not covered,national health,pay,full price,treatments,demand,solutions,immense,cost,cheaper
PersonInImage: